Addiction

Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost
Craig Rodgers, Krista J Siefried, Alison Ritter, Vendula Belackova, Carla Treloar, Marianne Jauncey, Nadine Ezard, Darren Roberts, Maureen Steele, Willem van den Brink, John Strang, Eugenia Oviedo-Joekes, Nicholas Lintzeris, Adrian John Dunlop, James Bell

BMJ Open Aug 2024, 14 (8) e082553; DOI: 10.1136/bmjopen-2023-082553
Prevalence of substance and hazardous alcohol use and their association with risky sexual behaviour among youth: findings from a population-based survey in Zimbabwe
Kudzai Hlahla, Steven Chifundo Azizi, Victoria Simms, Chido Dziva Chikwari, Ethel Dauya, Tsitsi Bandason, Mandikudza Tembo, Constancia Mavodza, Katharina Kranzer, Rashida Ferrand

BMJ Open Jun 2024, 14 (6) e080993; DOI: 10.1136/bmjopen-2023-080993
Effect of HIV and substance use disorder comorbidity on the placenta, fetal and maternal health outcomes: systematic review and meta-analysis protocol
Mende Mensa Sorato, Tsegaye Alemu, Alemayehu Toma, Getahun Paulos, Shewangizaw Mekonnen

BMJ Open May 2024, 14 (5) e083037; DOI: 10.1136/bmjopen-2023-083037
What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada
Ruyu Yan, Megan Kurz, B Carolina Guerra-Alejos, Jeong Eun Min, Paxton Bach, Sander Greenland, Paul Gustafson, Ehsan Karim, P Todd Korthuis, Tom Loughin, Lawrence McCandless, Robert W Platt, Kevin Schnepel, Shaun Seaman, M Eugenia Socías, Evan Wood, Hui Xie, Bohdan Nosyk

BMJ Open Apr 2024, 14 (4) e083453; DOI: 10.1136/bmjopen-2023-083453
Professionals’ perspectives on interventions to reduce problematic alcohol use in older adults: a realist evaluation of working elements
Fieke A E van den Bulck, Rikste Knijff, Rik Crutzen, Dike van de Mheen, Rob H L M Bovens, Sarah E Stutterheim, Ien Van de Goor, Andrea D Rozema

BMJ Open Apr 2024, 14 (4) e077851; DOI: 10.1136/bmjopen-2023-077851
Intersection of gambling with smoking and alcohol use in Great Britain: a cross-sectional survey in October 2022
Loren Kock, Sharon Cox, Lion Shahab, Amanda Roberts, Steve Sharman, Vera Buss, Jamie Brown

BMJ Open Apr 2024, 14 (4) e079633; DOI: 10.1136/bmjopen-2023-079633
Facilitators of and barriers to healthcare providers’ adoption of harm reduction in cannabis use: a scoping review protocol
Roula Haddad, Christian Dagenais, Christophe Huynh, Jean-Sébastien Fallu

BMJ Open Apr 2024, 14 (4) e078427; DOI: 10.1136/bmjopen-2023-078427
Indications of alcohol or drug use disorders in five different national registers in Sweden: a cross-sectional population-based study
Andreas Lundin, Anna-Karin Danielsson, Christina Dalman, Anna-Clara Hollander

BMJ Open Sep 2023, 13 (9) e070744; DOI: 10.1136/bmjopen-2022-070744
Understanding polysubstance use at the daily and event levels: protocol for a mixed-methods qualitative and ecological momentary assessment study in a community-based sample of people who use illicit drugs in Oakland, California, USA
Jennifer Lorvick, Jordana Hemberg, Madeleine J George, Joy Piontak, Megan L Comfort

BMJ Open Sep 2023, 13 (9) e075380; DOI: 10.1136/bmjopen-2023-075380
Do smoking abstinence periods among pregnant smokers improve birth weight? A secondary analysis of a randomised, controlled trial
Ivan Berlin, Leontine Goldzahl, Florence Jusot, Noemi Berlin

BMJ Open Mar 2024, 14 (3) e082876; DOI: 10.1136/bmjopen-2023-082876

Main menu

Addiction

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Addiction

Pages